Heidi Higginson is an accomplished executive in the pharmaceutical industry with extensive experience in global pricing and market access. Serving as Vice President of Global Pricing & Market Access at Vertex Pharmaceuticals since 2017, Heidi previously held the role of Vice President of Pricing & Reimbursement Strategy at Biogen. Prior experience includes leadership positions at Amgen, where responsibilities encompassed international pricing and therapeutic area management for hematology, oncology, and immunology. Heidi's background also features a senior role at PRICESPECTIVE, LLC, where strategic consulting for pharmaceutical companies was emphasized, as well as principal consulting at Cambridge Pharma Consultancy/IMS Health. A key contributor to the successful launch of Humira during tenure at Abbott Laboratories, Heidi holds multiple degrees from the University of Illinois Urbana-Champaign and is pursuing further education through The George Washington University's Executive Education School.
This person is not in any teams
Vertex Pharmaceuticals
70 followers
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.